The pharmacological characteristics of molecular-based inherited salt-losing tubulopathies.
Nozu, Kandai
The pharmacological characteristics of molecular-based inherited salt-losing tubulopathies. [electronic resource] - The Journal of clinical endocrinology and metabolism Dec 2010 - E511-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1945-7197
10.1210/jc.2010-0392 doi
Adolescent
Adult
Bartter Syndrome--drug therapy
Child
DNA Mutational Analysis
Diuretics--therapeutic use
Exons--genetics
Female
Frameshift Mutation
Furosemide--therapeutic use
Gitelman Syndrome--drug therapy
Humans
Male
Mutation
Receptors, Drug--genetics
Sequence Deletion--genetics
Sodium-Potassium-Chloride Symporters--genetics
Solute Carrier Family 12, Member 1
Solute Carrier Family 12, Member 3
Symporters--genetics
Thiazides--therapeutic use
Young Adult
The pharmacological characteristics of molecular-based inherited salt-losing tubulopathies. [electronic resource] - The Journal of clinical endocrinology and metabolism Dec 2010 - E511-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1945-7197
10.1210/jc.2010-0392 doi
Adolescent
Adult
Bartter Syndrome--drug therapy
Child
DNA Mutational Analysis
Diuretics--therapeutic use
Exons--genetics
Female
Frameshift Mutation
Furosemide--therapeutic use
Gitelman Syndrome--drug therapy
Humans
Male
Mutation
Receptors, Drug--genetics
Sequence Deletion--genetics
Sodium-Potassium-Chloride Symporters--genetics
Solute Carrier Family 12, Member 1
Solute Carrier Family 12, Member 3
Symporters--genetics
Thiazides--therapeutic use
Young Adult